Repeated treatment with the ADC N41mab-vcMMAE, which targets nectin-4 and has MMAE as its payload, in mice xenografted with the SUM190 breast cancer cell line induced refractory tumors which were found to overexpress ABCB1 as the mechanism of resistance[30]. This evidence concerns the gene NECTIN4 and breast cancer.